These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 7350917
1. Effect of C1-inhibitor, benzamidine, and heat treatment on the hydrolytic activity of a subcomponent of the first component of human complement, C1s. Takahashi K, Nagasawa S, Koyama J. Biochim Biophys Acta; 1980 Jan 11; 611(1):196-204. PubMed ID: 7350917 [No Abstract] [Full Text] [Related]
2. Inhibition of four human serine proteases by substituted benzamidines. Andrews JM, Roman DP, Bing DH. J Med Chem; 1978 Dec 11; 21(12):1202-7. PubMed ID: 152812 [Abstract] [Full Text] [Related]
3. Functional analysis of activated C1s, a subcomponent of the first component of human complement, by monoclonal antibodies. Matsumoto M, Nagaki K. J Immunol; 1986 Nov 01; 137(9):2907-12. PubMed ID: 2428878 [Abstract] [Full Text] [Related]
5. Exo-site affinity labeling of C1s, a subcomponent of the first component of complement, by m-[o-(2-chloro-5-fluorosulfonylphenylureido)phenoxybutoxy]benzamidine. Bing DH, Laura R, Andrews JM, Cory M. Biochemistry; 1978 Dec 26; 17(26):5713-8. PubMed ID: 310315 [No Abstract] [Full Text] [Related]
6. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function. Giclas PC. J Immunol; 1982 Jul 26; 129(1):168-72. PubMed ID: 6979566 [Abstract] [Full Text] [Related]
8. Heparin-stimulated modification of C1-inhibitor by subcomponent C1s of human complement. Weiss V, Engel J. Hoppe Seylers Z Physiol Chem; 1983 Mar 26; 364(3):295-301. PubMed ID: 6602754 [Abstract] [Full Text] [Related]
11. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r. Wisnieski JJ, Knauss TC, Yike I, Dearborn DG, Narvy RL, Naff GB. J Immunol; 1994 Mar 15; 152(6):3199-209. PubMed ID: 8144914 [Abstract] [Full Text] [Related]
15. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement. Peitsch MC, Kovacsovics TJ, Tschopp J, Isliker H. J Immunol; 1987 Mar 15; 138(6):1871-6. PubMed ID: 3029223 [Abstract] [Full Text] [Related]
17. The unactivated form of the first component of human complement, C1. Gigli I, Porter RR, Sim RB. Biochem J; 1976 Sep 01; 157(3):541-8. PubMed ID: 985398 [Abstract] [Full Text] [Related]
18. Biosynthesis of the first component of complement by human fibroblasts. Reid KB, Solomon E. Biochem J; 1977 Dec 01; 167(3):647-60. PubMed ID: 603627 [Abstract] [Full Text] [Related]
19. Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency. Smith MA, Kerr MA. Immunology; 1985 Nov 01; 56(3):561-70. PubMed ID: 2934317 [Abstract] [Full Text] [Related]
20. Inhibition of the reconstitution of the haemolytic activity of the first component of human complement by a pepsin-derived fragment of subcomponent C1q. Reid KB, Sim RB, Faiers AP. Biochem J; 1977 Feb 01; 161(2):239-45. PubMed ID: 322655 [Abstract] [Full Text] [Related] Page: [Next] [New Search]